Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncternal Therapeutics, Inc. has filed 1,606 SEC EDGAR filings since 21 Aug 2003

SEC filing history

Showing 476-500 of 1,000 matching filings.

Per page
25
Current page
20
8-K File 000-50549

8-K

Filing date
15 Nov 2017
Reporting date
14 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-50549

CT ORDER filing

Filing date
06 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-221040

424B3

Filing date
03 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-221040

EFFECT filing

Filing date
02 Nov 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
31 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-221040

S-3

Filing date
20 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-296459

D filing

Filing date
12 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79588

SCHEDULE 13G

Filing date
10 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-79588

SCHEDULE 13G

Filing date
05 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
04 Oct 2017
Reporting date
02 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SC 13D/A FILING

Filing date
03 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-79588

SC 13D/A

Filing date
02 Oct 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
02 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
29 Sep 2017
Reporting date
25 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
13 Sep 2017
Reporting date
13 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-50549

8-K

Filing date
14 Aug 2017
Reporting date
14 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 -

Filing date
05 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .